Norepinephrine Bitartrate Solution
Product Images NDC 63323-940

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 63323-940). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nor0f 0007 01

Chemical structure diagram of norepinephrine bitartrate monohydrate showing the molecular components of norepinephrine and the bitartrate salt with associated water molecule.*

FDA Label Image

Nor0f 0007 02

FDA Label Image

Nor0f 0007 03

Norepinephrine Bitartrate Injection USP 4 mg per 4 mL (1 mg per mL) solution for intravenous infusion. The label indicates single-dose vials, 10 vials of 4 mL each, labeled by Fresenius Kabi USA, LLC. The packaging includes warnings about drug potency, sulfites, and instructions to dilute before use and protect from light.*

FDA Label Image

Nor0f 0007 04

Norepinephrine Bitartrate Injection, USP label showing 4 mg per 4 mL (1 mg per mL) solution for intravenous infusion. The label indicates it is a 4 mL single-dose vial containing sulfites, with instructions to discard unused portion. The product is prescription only from Fresenius Kabi USA, LLC, NDC 63323-940-21.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.